Pretomanid in drug-resistant tuberculosis: a profile of its use Matt Shirley Adis Drug Q&A 29 May 2020 Pages: 273 - 279
Be alert for macrophage activation syndrome in seriously sick children with underlying pro-inflammatory disorders Caroline FentonYoung-A Heo Disease Management 29 May 2020 Pages: 280 - 285
Adverse drug reactions and interactions: first reports and special situations Drug Reactions and Interactions 24 June 2020 Pages: 286 - 287
Effectiveness of duloxetine for remnant pain relief in patients with rheumatoid arthritis despite remission Ichiro YoshiiTatsumi Chijiwa Short Communication 25 May 2020 Pages: 288 - 292
Is Pakistan on track to have COVID-19 transmission and mortality rates similar to those of Italy, Iran or the USA? Bilal JavedAbdullah SarwerZia-ur-Rehman Mashwani Commentary 15 April 2020 Pages: 293 - 297
Within a large healthcare system, the incidence of positive COVID-19 results and mortality are lower in patients on chronic hydroxychloroquine therapy Soma SenAnn WernerAditya Shekhar Commentary 20 May 2020 Pages: 298 - 299
Amid COVID-19 drug shortages: proposed plan for reprocessing and reusing salbutamol pressurized metered dose inhalers (pMDIs) for shared use Ali ElbeddiniAniko Yeats Commentary 20 May 2020 Pages: 300 - 302
Assessment of the utilization pattern of chemotherapy agents in patients with head and neck cancer in an oncology hospital Avinash KhadelaBhavin Vyas Original Research Article 21 April 2020 Pages: 303 - 309
Disability and self-reported adverse drug events among patients with chronic diseases Haichao ZhangEunjeong KangJong Wha Chang Original Research Article 05 May 2020 Pages: 310 - 318
Knowledge, attitude and preventive practices related to COVID-19: a cross-sectional study in two Pakistani university populations Muhammad SalmanZia Ul MustafaZikria Saleem Short Communication 09 May 2020 Pages: 319 - 325
